• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Why J&J Bought a Big Piece of Elan

    Morningstar's Damien Conover and Alex Morozov discuss what J&J's stake in biotech Elan means for both companies.

  2. Upside Attraction to J&J

    Morningstar's Damien Conover discusses the prospects for J&J's stent and drug pipelines.

  3. What Makes a Dividend Stock Tick

    Morningstar's Josh Peters on considering yield and growth when looking for dividend-stock opportunities.

  4. Don't Invest With the Rearview Mirror

    Bonds may have done well over the last decade but dividend paying stocks like J&J may be the best bet for the next ten years says Morningstar's Josh Peters.

  1. Getting Serious About Saving and Investing

    A 36-year-old IT executive crafts a plan for fulfilling his financial ambitions.

  2. Outlook for 2013 – Peroni Report

     

  3. Corporate Models For Corporate Governance: Johnson & Johnson Trust

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.